• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C 反应蛋白水平可预测慢性阻塞性肺疾病患者的细菌恶化。

C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.

机构信息

Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Am J Med Sci. 2013 Mar;345(3):190-4. doi: 10.1097/MAJ.0b013e318253c921.

DOI:10.1097/MAJ.0b013e318253c921
PMID:23221507
Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) causes a high rate of morbidity worldwide and predicting a bacterial cause of an exacerbation of COPD is difficult.

METHOD

In this study, patient serum was obtained and C-reactive protein (CRP) levels were measured using an automated latex-enhanced turbidimetric assay. Sputum samples were obtained and evaluated microscopically. The relationship between CRP and the bacterial colonies in sputum in 81 patients with an exacerbation of COPD was assessed. Receiver operating characteristic (ROC) curves and the respective areas under the curve (AUCs) were calculated. Data from 64 patients with bacterial acute exacerbation of COPD (AECOPD) were compared with those of 37 patients with no documented bacterial AECOPD. Results categorized according to the nature of sputum as mucoid or purulent were also compared.

RESULTS

High median CRP levels were observed in bacterial AECOPD compared with nonbacterial AECOPD. The ideal cutoff point for distinguishing patients with bacterial AECOPD from those with nonbacterial AECOPD was 19.65 mg/L (sensitivity, 78.18%; specificity, 84.61%; AUC, 0.832). In patients with mucoid sputum, the cutoff point was 15.21 mg/L and the area under the ROC curve 0.86, with a sensitivity of 81.5% and a specificity of 77.8%. Purulent sputum had a significantly higher CRP level than mucoid sputum, but with an AUC of only 0.617 (95% confidence interval, 0.49-0.74) to diagnosis bacterial AECOPD.

CONCLUSIONS

In adult patients with symptoms of AECOPD, an elevated serum CRP level of >19.6 mg/L indicates bacterial exacerbation. In patients with AECOPD with mucoid sputum, an elevated CRP level of >15.21 mg/L indicates bacterial infection, which may be a useful clinical marker for therapy of this disease.

摘要

背景

慢性阻塞性肺疾病(COPD)在全球范围内导致高发病率,预测 COPD 加重的细菌病因较为困难。

方法

本研究中,采集患者血清并使用自动乳胶增强比浊法测量 C 反应蛋白(CRP)水平。采集痰标本并进行显微镜评估。评估 81 例 COPD 加重患者的 CRP 与痰中细菌菌落之间的关系。计算受试者工作特征(ROC)曲线和相应的曲线下面积(AUCs)。将 64 例细菌急性加重的 COPD(AECOPD)患者的数据与 37 例无细菌 AECOPD 记录的患者进行比较。还比较了根据痰的性质分类为黏液性或脓性的结果。

结果

与非细菌性 AECOPD 相比,细菌性 AECOPD 患者的 CRP 中位数水平较高。区分细菌性 AECOPD 患者和非细菌性 AECOPD 患者的最佳截断值为 19.65mg/L(敏感性为 78.18%,特异性为 84.61%,AUC 为 0.832)。在黏液性痰患者中,截断值为 15.21mg/L,ROC 曲线下面积为 0.86,敏感性为 81.5%,特异性为 77.8%。脓性痰的 CRP 水平明显高于黏液性痰,但诊断细菌性 AECOPD 的 AUC 仅为 0.617(95%置信区间为 0.49-0.74)。

结论

在出现 AECOPD 症状的成年患者中,血清 CRP 水平升高>19.6mg/L 提示细菌加重。在 AECOPD 患者中,CRP 水平升高>15.21mg/L 提示细菌感染,这可能是治疗该疾病的有用临床标志物。

相似文献

1
C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.C 反应蛋白水平可预测慢性阻塞性肺疾病患者的细菌恶化。
Am J Med Sci. 2013 Mar;345(3):190-4. doi: 10.1097/MAJ.0b013e318253c921.
2
C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.慢性阻塞性肺疾病患者的C反应蛋白水平:感染的作用
Med Princ Pract. 2008;17(3):202-8. doi: 10.1159/000117793. Epub 2008 Apr 10.
3
Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.降钙素原、C反应蛋白及血中性粒细胞/淋巴细胞比值水平对慢性阻塞性肺疾病急性加重期住院患者细菌感染预测的诊断价值比较
Wien Klin Wochenschr. 2015 Oct;127(19-20):756-63. doi: 10.1007/s00508-014-0690-6. Epub 2015 Jan 14.
4
Reactive oxygen species in peripheral blood and sputum neutrophils during bacterial and nonbacterial acute exacerbation of chronic obstructive pulmonary disease.外周血和痰中性粒细胞中的活性氧在细菌性和非细菌性慢性阻塞性肺疾病急性加重期的变化。
Inflammation. 2013 Dec;36(6):1485-93. doi: 10.1007/s10753-013-9690-3.
5
Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.降钙素原和C反应蛋白无法区分需要前往急诊科就诊的慢性阻塞性肺疾病急性加重患者是细菌感染还是病毒感染。
Int J Chron Obstruct Pulmon Dis. 2015 Apr 13;10:767-74. doi: 10.2147/COPD.S76740. eCollection 2015.
6
Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对慢性阻塞性肺疾病急性加重患者院内死亡率的预后作用
Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2285-2290. doi: 10.2147/COPD.S141760. eCollection 2017.
7
Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients.慢性阻塞性肺疾病(COPD)患者急性加重期血清胰岛素样生长因子结合蛋白7(IGFBP7)水平升高。
Int J Chron Obstruct Pulmon Dis. 2017 Jun 19;12:1775-1780. doi: 10.2147/COPD.S132652. eCollection 2017.
8
Evaluation of new laboratory tests to discriminate bacterial from nonbacterial chronic obstructive pulmonary disease exacerbations.评估用于区分细菌性与非细菌性慢性阻塞性肺疾病急性加重的新型实验室检测方法。
Int J Lab Hematol. 2016 Dec;38(6):616-628. doi: 10.1111/ijlh.12550. Epub 2016 Jul 27.
9
The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation.血清降钙素原和高敏C反应蛋白水平在慢性阻塞性肺疾病急性加重期早期诊断中的应用
Exp Ther Med. 2017 Jul;14(1):193-198. doi: 10.3892/etm.2017.4496. Epub 2017 May 23.
10
Neutrophil CD64 Expression as a Diagnostic Marker in Patients Hospitalized with Exacerbations of COPD: A Prospective Observational Study.中性粒细胞CD64表达作为慢性阻塞性肺疾病急性加重期住院患者的诊断标志物:一项前瞻性观察研究。
Lung. 2015 Oct;193(5):717-24. doi: 10.1007/s00408-015-9762-2. Epub 2015 Jul 15.

引用本文的文献

1
Phenotypes of Exacerbations in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重的表型
J Clin Med. 2025 Apr 30;14(9):3132. doi: 10.3390/jcm14093132.
2
Management of Asthma and COPD Exacerbations in Adults in the ICU.成人重症监护病房中哮喘与慢性阻塞性肺疾病急性加重的管理
CHEST Crit Care. 2025 Mar;3(1). doi: 10.1016/j.chstcc.2024.100107. Epub 2024 Nov 8.
3
Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病加重的表型、病因型和内型。
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1026-1041. doi: 10.1164/rccm.202209-1748SO.
4
Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system.分析 17 种商业化即时检验 CRP 产品在基层医疗环境下支持患者管理的性能。
PLoS One. 2023 Jan 20;18(1):e0267516. doi: 10.1371/journal.pone.0267516. eCollection 2023.
5
Bacterial etiology and pneumococcal urinary antigen in moderate exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病中度加重期的细菌病因及肺炎球菌尿抗原
J Thorac Dis. 2022 Jul;14(7):2532-2543. doi: 10.21037/jtd-22-133.
6
Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis.生物标志物指导慢性阻塞性肺疾病急性加重(AECOPD)抗生素使用:系统评价和荟萃分析。
BMC Pulm Med. 2022 May 13;22(1):194. doi: 10.1186/s12890-022-01958-4.
7
Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.COPD 加重期痰液微生物组特征及其与临床指标的相关性。
J Transl Med. 2022 Feb 5;20(1):76. doi: 10.1186/s12967-022-03278-x.
8
Inflammatory Biomarkers Are Inaccurate Indicators of Bacterial Infection on Admission in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease-A Systematic Review and Diagnostic Accuracy Network Meta-Analysis.炎症生物标志物在慢性阻塞性肺疾病急性加重患者入院时并非细菌感染的准确指标——一项系统评价与诊断准确性网络荟萃分析
Front Med (Lausanne). 2021 Nov 18;8:639794. doi: 10.3389/fmed.2021.639794. eCollection 2021.
9
Antibiotics and COPD: Time to order a C-reactive protein test?抗生素与 COPD:是时候进行 C 反应蛋白检测了?
J Fam Pract. 2021 Jun;70(5):244-246. doi: 10.12788/jfp.0202.
10
MULTI-PHACET: multidimensional clinical phenotyping of hospitalised acute COPD exacerbations.多方面研究:住院急性慢性阻塞性肺疾病加重期的多维临床表型分析
ERJ Open Res. 2021 Jul 12;7(3). doi: 10.1183/23120541.00198-2021. eCollection 2021 Jul.